本报讯（刘进毛旭建姚瑶）近日，江苏省卫生健康委员会公布2024年度医学科研立项项目名单，《基于CRISPR技术的新型HIV基因型耐药筛查方案的构建及其临床应用研究》获重点项目支持，该项目由市疾控中心病原生物检验科王凤鸣研究员主持。

Additionally, Editas Medicine management will participate in the following upcoming investor conferences in March: To access the live webcasts of Editas Medicine’s presentations, please visit the ...

Call for Papers! Cas12-mediated Genome Editing in Plants . Ca. 01. Time Schedule . Submission deadline: Sunday, 30th November ...

Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, PhD, Caribou’s president and chief executive ...

三浦制药研究团队成功构建新一代CRISPR-Cas12a基因编辑系统，其基因定位精度较传统Cas9技术提升40%，可实现更高效、更低脱靶率的基因修复。 CHO细胞改造：提升生物制剂产能 三浦制药利用该技术对CHO细胞系（Chinese Hamster Ovary cells）进行改造，使单克隆抗体表达量 ...

Study advances gene-editing capabilities for cancer and medical research through genetic manipulations using Cas12a enzyme ...

Conventional CRISPR nucleases, including Cas9 and Cas12a, exceed the packaging limits of a single AAV vector, necessitating ...

A team of researchers from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has developed a ...

Researchers have revealed new details about the CRISPR-Cas5-HNH/Cascade complex, a variant of the type I-E CRISPR-Cas system, ...

A study published in Nature Communications and conducted by researchers from the Institute of Physics of the Chinese Academy of Sciences revealed new ...

“‘DuTracer’为单细胞水平的谱系追踪设立了新标准。”论文通讯作者彭广敦表示，该技术通过巧妙结合两种基因编辑工具CRISPR-Cas9和Cas12a，显著提升了细胞谱系追踪的精度和深度，为解析胚胎发育、器官再生及疾病机制提供了全新工具。